Symbols / DH Stock $1.04 +3.52% Definitive Healthcare Corp.

Healthcare • Health Information Services • United States • NMS
DH (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: SMA 50: SMA 200:
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Health Information Services
CEO Mr. Kevin D. Coop
Exch · Country NMS · United States
Market Cap 108.13M
Enterprise Value 193.99M
Income -138.93M
Sales 241.52M
FCF (ttm) 67.93M
Book/sh 2.70
Cash/sh 1.73
Employees 678
Insider 10d
IPO Sep 15, 2021
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E
Forward P/E 5.46
PEG
P/S 0.45
P/B 0.38
P/C
EV/EBITDA 5.46
EV/Sales 0.80
Quick Ratio 1.49
Current Ratio 1.64
Debt/Eq 45.56
LT Debt/Eq
EPS (ttm) -1.30
EPS next Y 0.19
EPS Growth
Revenue Growth -1.20%
EPS Gr Q/Q
Rev Gr Q/Q
Earnings (next) 2026-05-07
Earnings (prior) 2026-02-26
ROA -1.41%
ROE -40.42%
ROIC
Gross Margin 84.28%
Oper. Margin -10.91%
Profit Margin -57.52%
Shs Outstand 104.47M
Shs Float 37.31M
Insider Own 11.66%
Instit Own 88.58%
Short Float 6.40%
Short Ratio 5.91
Short Interest 2.60M
52W High 4.70
vs 52W High -77.98%
52W Low 0.92
vs 52W Low 12.50%
Beta 1.60
Impl. Vol. 50.00%
Rel Volume 0.35
Avg Volume 355.11K
Volume 124.84K
Target (mean) $2.41
Tgt Median $2.75
Tgt Low $1.00
Tgt High $3.50
# Analysts 8
Recom Hold
Prev Close $1.00
Price $1.03
Change 3.52%
About

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution. The company's platform consists of various functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate firms, financial institutions, marketing and advertising agencies.Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus Mean price target
2. Current target Latest analyst target
3. DCF / Fair value Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$1.03
Low
$1.00
High
$3.50
Mean
$2.41

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-03-30 main Barclays Underweight → Underweight $1
2026-02-27 main Canaccord Genuity Hold → Hold $3
2026-02-27 main Stephens & Co. Equal-Weight → Equal-Weight $2
2025-12-09 main Barclays Underweight → Underweight $3
2025-11-10 main Canaccord Genuity Hold → Hold $4
2025-08-08 main Stifel Buy → Buy $6
2025-05-12 main Goldman Sachs Neutral → Neutral $3
2025-03-04 main Goldman Sachs Neutral → Neutral $3
2025-03-03 main Barclays Underweight → Underweight $3
2025-01-16 reit Needham Hold → Hold
2025-01-13 down Barclays Equal-Weight → Underweight $4
2024-12-20 init Stephens & Co. — → Equal-Weight $5
2024-11-08 reit Needham — → Hold
2024-09-17 init BTIG — → Buy $7
2024-08-09 main Deutsche Bank Hold → Hold $5
2024-08-07 main Barclays Equal-Weight → Equal-Weight $4
2024-08-07 main Baird Neutral → Neutral $5
2024-08-06 main Morgan Stanley Equal-Weight → Equal-Weight $5
2024-08-06 reit Needham — → Hold
2024-07-31 main Stifel Buy → Buy $8
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-02-24 HELLER CASEY Chief Financial Officer 733,301 $0.00 $0
2026-02-24 PARIS JONATHAN Officer 481,505 $0.00 $0
2026-02-24 KRANTZ JASON RONALD Director and Beneficial Owner of more than 10% of a Class of Security 242,719 $0.00 $0
2026-02-24 COOP KEVIN Chief Executive Officer 1,735,437 $0.00 $0
2026-02-24 GRABOSKE BENJAMIN Officer 631,068 $0.00 $0
2026-01-05 HELLER CASEY Chief Financial Officer 195,313 $0.00 $0
2025-07-01 PARIS JONATHAN Officer 421,349 $0.00 $0
2025-06-10 HELLER CASEY Chief Financial Officer 485,881 $0.00 $0
2025-06-05 WINTERS KATHLEEN A Director 55,911 $0.00 $0
2025-06-05 STEPHENSON SCOTT G Director 55,911 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
241.52
-4.24%
252.20
+0.31%
251.41
+12.92%
222.65
Operating Revenue
241.52
-4.24%
252.20
+0.31%
251.41
+12.92%
222.65
Cost Of Revenue
58.25
+6.42%
54.73
+15.27%
47.48
+11.39%
42.62
Reconciled Cost Of Revenue
37.95
-6.71%
40.68
+17.11%
34.74
+34.31%
25.87
Gross Profit
183.28
-7.19%
197.47
-3.17%
203.93
+13.28%
180.03
Operating Expense
203.86
-1.62%
207.21
-11.77%
234.84
+8.63%
216.18
Research And Development
34.78
-4.77%
36.52
-13.96%
42.44
+21.64%
34.89
Selling General And Administration
133.26
+0.14%
133.07
-13.25%
153.40
+8.68%
141.15
Selling And Marketing Expense
81.64
-2.59%
83.81
-11.35%
94.53
+5.52%
89.58
General And Administrative Expense
51.63
+4.79%
49.27
-16.30%
58.86
+14.16%
51.56
Other Gand A
51.63
+4.79%
49.27
-16.30%
58.86
+14.16%
51.56
Total Expenses
262.10
+0.06%
261.94
-7.22%
282.33
+9.09%
258.81
Operating Income
-20.58
-111.30%
-9.74
+68.49%
-30.91
+14.50%
-36.15
Total Operating Income As Reported
-224.27
+68.45%
-710.82
-115.53%
-329.80
-648.81%
-44.04
EBITDA
-141.86
+74.99%
-567.24
-135.15%
-241.23
-1019.77%
26.23
Normalized EBITDA
62.34
-53.42%
133.84
+132.11%
57.66
+69.01%
34.12
Reconciled Depreciation
56.11
+8.60%
51.67
-0.16%
51.75
-9.06%
56.90
EBIT
-197.97
+68.01%
-618.91
-111.25%
-292.98
-855.04%
-30.68
Total Unusual Items
-204.19
+70.87%
-701.08
-134.56%
-298.89
-3688.20%
-7.89
Total Unusual Items Excluding Goodwill
-204.19
+70.87%
-701.08
-134.56%
-298.89
-3688.20%
-7.89
Special Income Charges
-204.19
+70.87%
-701.08
-134.56%
-298.89
-3688.20%
-7.89
Other Special Charges
0.51
Impairment Of Capital Assets
196.06
-71.54%
688.85
+139.68%
287.40
0.00
Restructuring And Mergern Acquisition
7.62
-37.64%
12.22
+6.41%
11.49
+45.61%
7.89
Net Income
-138.93
+66.37%
-413.12
-104.12%
-202.39
-2702.38%
-7.22
Pretax Income
-209.26
+66.98%
-633.75
-105.64%
-308.18
-635.92%
-41.88
Net Non Operating Interest Income Expense
-4.34
-1670.20%
-0.24
+84.28%
-1.56
+81.47%
-8.41
Interest Expense Non Operating
11.29
-23.92%
14.84
-2.41%
15.20
+35.74%
11.20
Net Interest Income
-4.34
-1670.20%
-0.24
+84.28%
-1.56
+81.47%
-8.41
Interest Expense
11.29
-23.92%
14.84
-2.41%
15.20
+35.74%
11.20
Interest Income Non Operating
6.95
-52.36%
14.59
+6.95%
13.64
+389.56%
2.79
Interest Income
6.95
-52.36%
14.59
+6.95%
13.64
+389.56%
2.79
Other Income Expense
-184.34
+70.45%
-623.76
-126.24%
-275.71
-10353.25%
2.69
Other Non Operating Income Expenses
19.86
-74.32%
77.32
+233.58%
23.18
+119.10%
10.58
Gain On Sale Of Security
10.24
Tax Provision
-9.96
+76.46%
-42.30
-127.99%
-18.55
-4.83%
-17.70
Tax Rate For Calcs
0.00
-28.79%
0.00
+10.80%
0.00
-71.33%
0.00
Tax Effect Of Unusual Items
-9.70
+79.26%
-46.76
-159.89%
-17.99
-985.95%
-1.66
Net Income Including Noncontrolling Interests
-199.30
+66.30%
-591.45
-104.21%
-289.63
-1097.85%
-24.18
Net Income From Continuing Operation Net Minority Interest
-138.93
+66.37%
-413.12
-104.12%
-202.39
-2702.38%
-7.22
Net Income From Continuing And Discontinued Operation
-138.93
+66.37%
-413.12
-104.12%
-202.39
-2702.38%
-7.22
Net Income Continuous Operations
-199.30
+66.30%
-591.45
-104.21%
-289.63
-1097.85%
-24.18
Minority Interests
60.37
-66.15%
178.32
+104.41%
87.24
+414.47%
16.96
Normalized Income
55.56
-76.96%
241.19
+207.22%
78.51
+8038.91%
-0.99
Net Income Common Stockholders
-138.93
+66.37%
-413.12
-104.12%
-202.39
-2702.38%
-7.22
Otherunder Preferred Stock Dividend
0.00
0.00
Diluted EPS
-3.54
-97.77%
-1.79
-2883.33%
-0.06
Basic EPS
-3.54
-97.77%
-1.79
-2883.33%
-0.06
Basic Average Shares
116.64
+3.44%
112.76
+11.52%
101.11
Diluted Average Shares
116.64
+3.44%
112.76
+11.52%
101.11
Diluted NI Availto Com Stockholders
-138.93
+66.37%
-413.12
-104.12%
-202.39
-2702.38%
-7.22
Depreciation Amortization Depletion Income Statement
35.82
-4.78%
37.62
-3.56%
39.01
-2.83%
40.15
Depreciation And Amortization In Income Statement
35.82
-4.78%
37.62
-3.56%
39.01
-2.83%
40.15
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
735.49
-32.49%
1,089.39
-40.34%
1,825.90
-13.98%
2,122.62
Current Assets
257.61
-30.41%
370.17
-6.03%
393.93
-4.79%
413.75
Cash Cash Equivalents And Short Term Investments
180.89
-37.66%
290.16
-5.81%
308.07
-7.17%
331.87
Cash And Cash Equivalents
163.63
+55.28%
105.38
-19.54%
130.98
-10.86%
146.93
Other Short Term Investments
17.26
-90.66%
184.79
+4.34%
177.09
-4.24%
184.94
Receivables
51.98
-2.36%
53.23
-10.16%
59.25
+0.77%
58.80
Accounts Receivable
52.80
-3.32%
54.62
-9.28%
60.21
+0.71%
59.78
Receivables Adjustments Allowances
-1.44
+31.98%
-2.11
+8.21%
-2.30
-23.68%
-1.86
Other Receivables
0.61
-15.80%
0.73
-45.91%
1.35
+52.78%
0.88
Prepaid Assets
Current Deferred Assets
12.77
-7.06%
13.74
+1.82%
13.49
+29.87%
10.39
Other Current Assets
11.97
-8.19%
13.04
-0.61%
13.12
+3.42%
12.69
Total Non Current Assets
477.89
-33.55%
719.22
-49.77%
1,431.97
-16.20%
1,708.88
Net PPE
18.07
+59.78%
11.31
-19.57%
14.06
-0.57%
14.14
Gross PPE
27.58
+46.93%
18.77
-6.26%
20.02
+5.71%
18.94
Accumulated Depreciation
-9.51
-27.45%
-7.46
-25.17%
-5.96
-24.22%
-4.80
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
20.34
+115.67%
9.43
+16.55%
8.09
+13.54%
7.13
Construction In Progress
Other Properties
5.39
-28.28%
7.52
-21.61%
9.59
-0.90%
9.68
Leases
1.85
+1.48%
1.82
-22.20%
2.34
+9.56%
2.13
Goodwill And Other Intangible Assets
444.70
-35.66%
691.22
-50.56%
1,398.20
-16.55%
1,675.45
Goodwill
197.22
-49.85%
393.28
-63.42%
1,075.08
-18.85%
1,324.73
Other Intangible Assets
247.48
-16.94%
297.93
-7.80%
323.12
-7.87%
350.72
Investments And Advances
0.00
Non Current Deferred Assets
12.84
-10.77%
14.39
-16.92%
17.32
+18.66%
14.60
Non Current Deferred Taxes Assets
Other Non Current Assets
2.28
-1.00%
2.30
-3.69%
2.39
-49.01%
4.68
Total Liabilities Net Minority Interest
356.50
-26.07%
482.19
-23.06%
626.73
-2.18%
640.68
Current Liabilities
156.79
-2.71%
161.16
-5.58%
170.68
+21.39%
140.61
Payables And Accrued Expenses
41.75
-9.64%
46.20
-7.25%
49.81
+80.18%
27.65
Payables
14.29
-45.97%
26.45
-25.31%
35.41
+125.73%
15.69
Accounts Payable
3.60
-66.59%
10.76
+85.99%
5.79
+46.58%
3.95
Current Accrued Expenses
27.46
+38.99%
19.76
+37.13%
14.41
+20.45%
11.96
Total Tax Payable
10.69
-31.83%
15.68
-47.06%
29.62
+152.35%
11.74
Current Debt And Capital Lease Obligation
11.43
-29.27%
16.16
+1.06%
15.99
+58.07%
10.12
Current Debt
8.75
-36.36%
13.75
+0.00%
13.75
+60.00%
8.59
Other Current Borrowings
8.75
-36.36%
13.75
+0.00%
13.75
+60.00%
8.59
Current Capital Lease Obligation
2.68
+11.25%
2.41
+7.55%
2.24
+47.21%
1.52
Current Deferred Liabilities
96.99
+3.90%
93.34
-4.14%
97.38
-2.32%
99.69
Current Deferred Revenue
96.99
+3.90%
93.34
-4.14%
97.38
-2.32%
99.69
Other Current Liabilities
6.62
+21.33%
5.46
-27.25%
7.50
+137.67%
3.16
Total Non Current Liabilities Net Minority Interest
199.71
-37.79%
321.03
-29.60%
456.05
-8.80%
500.07
Long Term Debt And Capital Lease Obligation
161.24
-31.95%
236.95
-5.95%
251.94
-5.19%
265.73
Long Term Debt
156.09
-31.95%
229.37
-5.44%
242.57
-5.16%
255.76
Long Term Capital Lease Obligation
5.15
-32.09%
7.59
-19.06%
9.37
-5.99%
9.97
Tradeand Other Payables Non Current
19.21
-61.20%
49.51
-61.01%
127.00
-18.12%
155.11
Non Current Deferred Liabilities
17.02
-32.26%
25.12
-62.60%
67.17
-11.58%
75.97
Non Current Deferred Revenue
2.38
+7346.88%
0.03
+255.56%
0.01
-96.19%
0.24
Non Current Deferred Taxes Liabilities
14.63
-41.67%
25.09
-62.65%
67.16
-11.32%
75.74
Other Non Current Liabilities
2.25
-76.22%
9.45
-4.88%
9.93
+205.57%
3.25
Stockholders Equity
281.11
-36.74%
444.38
-48.41%
861.36
-9.23%
948.92
Common Stock Equity
281.11
-36.74%
444.38
-48.41%
861.36
-9.23%
948.92
Capital Stock
0.10
-8.77%
0.11
-2.56%
0.12
+11.43%
0.10
Common Stock
0.10
-8.77%
0.11
-2.56%
0.12
+11.43%
0.10
Share Issued
104.02
-8.72%
113.95
-2.24%
116.56
+10.87%
105.14
Ordinary Shares Number
104.02
-8.72%
113.95
-2.24%
116.56
+10.87%
105.14
Additional Paid In Capital
1,061.96
-2.16%
1,085.44
-0.10%
1,086.58
+11.99%
970.21
Retained Earnings
-779.51
-21.69%
-640.57
-181.63%
-227.45
-807.55%
-25.06
Gains Losses Not Affecting Retained Earnings
-1.45
-137.70%
-0.61
-128.92%
2.11
-42.50%
3.67
Minority Interest
97.88
-39.88%
162.82
-51.80%
337.82
-36.62%
533.03
Other Equity Adjustments
-1.45
-137.70%
-0.61
-128.92%
2.11
-42.50%
3.67
Total Equity Gross Minority Interest
378.99
-37.58%
607.19
-49.37%
1,199.17
-19.08%
1,481.94
Total Capitalization
437.20
-35.11%
673.74
-38.97%
1,103.92
-8.36%
1,204.68
Working Capital
100.82
-51.76%
209.01
-6.38%
223.25
-18.27%
273.13
Invested Capital
445.95
-35.13%
687.49
-38.49%
1,117.67
-7.88%
1,213.28
Total Debt
172.67
-31.78%
253.11
-5.53%
267.93
-2.87%
275.85
Net Debt
1.21
-99.12%
137.74
+9.89%
125.34
+6.74%
117.42
Capital Lease Obligations
7.83
-21.64%
9.99
-13.93%
11.61
+1.05%
11.49
Net Tangible Assets
-163.58
+33.73%
-246.84
+54.02%
-536.84
+26.11%
-726.54
Tangible Book Value
-163.58
+33.73%
-246.84
+54.02%
-536.84
+26.11%
-726.54
Available For Sale Securities
Interest Payable
Investmentin Financial Assets
0.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
53.78
-7.59%
58.20
+41.29%
41.19
+15.77%
35.58
Cash Flow From Continuing Operating Activities
53.78
-7.59%
58.20
+41.29%
41.19
+15.77%
35.58
Net Income From Continuing Operations
-199.30
+66.30%
-591.45
-104.21%
-289.63
-1097.85%
-24.18
Depreciation Amortization Depletion
56.11
+8.60%
51.67
-0.16%
51.75
-9.06%
56.90
Depreciation
3.30
+47.13%
2.25
+14.95%
1.95
-10.94%
2.19
Amortization Cash Flow
52.81
+6.85%
49.42
-0.75%
49.80
-8.98%
54.71
Depreciation And Amortization
56.11
+8.60%
51.67
-0.16%
51.75
-9.06%
56.90
Amortization Of Intangibles
52.81
+6.85%
49.42
-0.75%
49.80
-8.98%
54.71
Other Non Cash Items
13.02
-16.58%
15.60
+10.48%
14.12
+19.77%
11.79
Stock Based Compensation
29.14
-23.48%
38.09
-21.86%
48.74
+33.77%
36.43
Provisionand Write Offof Assets
-0.23
-124.50%
0.95
-31.08%
1.37
+3.70%
1.32
Asset Impairment Charge
196.53
-71.47%
688.85
+139.68%
287.40
0.00
Deferred Tax
-32.58
+72.75%
-119.58
-183.48%
-42.18
-53.26%
-27.52
Deferred Income Tax
-32.58
+72.75%
-119.58
-183.48%
-42.18
-53.26%
-27.52
Operating Gains Losses
0.51
Change In Working Capital
-9.42
+63.69%
-25.93
+14.65%
-30.39
-58.48%
-19.17
Change In Receivables
1.38
-75.69%
5.69
+601.97%
0.81
+106.13%
-13.22
Changes In Account Receivables
1.38
-75.69%
5.69
+601.97%
0.81
+106.13%
-13.22
Change In Prepaid Assets
-2.25
+71.28%
-7.83
-9.45%
-7.16
-5534.65%
-0.13
Change In Payables And Accrued Expense
-1.09
+80.07%
-5.46
-510.38%
1.33
-57.62%
3.14
Change In Payable
-1.09
+80.07%
-5.46
-510.38%
1.33
-57.62%
3.14
Change In Account Payable
-1.09
+80.07%
-5.46
-510.38%
1.33
-57.62%
3.14
Change In Other Working Capital
-7.46
+57.91%
-17.73
+30.09%
-25.37
-890.24%
-2.56
Change In Other Current Liabilities
0.00
+100.00%
-0.60
0.00
+100.00%
-6.40
Investing Cash Flow
153.88
+682.66%
-26.41
+16.91%
-31.78
+87.23%
-248.90
Cash Flow From Continuing Investing Activities
153.88
+682.66%
-26.41
+16.91%
-31.78
+87.23%
-248.90
Net PPE Purchase And Sale
-16.72
-35.45%
-12.34
-314.65%
-2.98
+64.24%
-8.33
Purchase Of PPE
-16.72
-35.45%
-12.34
-314.65%
-2.98
+64.24%
-8.33
Capital Expenditure
-16.72
-35.45%
-12.34
-314.65%
-2.98
+64.24%
-8.33
Net Investment Purchase And Sale
170.59
+31986.92%
-0.54
-103.30%
16.22
+108.80%
-184.28
Purchase Of Investment
-64.06
+78.95%
-304.30
-17.40%
-259.21
+23.30%
-337.96
Sale Of Investment
234.66
-22.75%
303.77
+10.29%
275.43
+79.22%
153.68
Net Business Purchase And Sale
0.00
+100.00%
-13.53
+69.95%
-45.02
+20.02%
-56.30
Purchase Of Business
0.00
+100.00%
-13.53
+69.95%
-45.02
+20.02%
-56.30
Financing Cash Flow
-150.79
-165.71%
-56.75
-121.81%
-25.58
+4.17%
-26.70
Cash Flow From Continuing Financing Activities
-150.79
-165.71%
-56.75
-121.81%
-25.58
+4.17%
-26.70
Net Issuance Payments Of Debt
-77.81
-465.91%
-13.75
-60.00%
-8.59
-25.00%
-6.88
Issuance Of Debt
175.00
0.00
0.00
0.00
Repayment Of Debt
-252.81
-1738.64%
-13.75
-60.00%
-8.59
-25.00%
-6.88
Long Term Debt Issuance
175.00
0.00
0.00
0.00
Long Term Debt Payments
-252.81
-1738.64%
-13.75
-60.00%
-8.59
-25.00%
-6.88
Net Long Term Debt Issuance
-77.81
-465.91%
-13.75
-60.00%
-8.59
-25.00%
-6.88
Short Term Debt Issuance
0.00
Short Term Debt Payments
0.00
Net Short Term Debt Issuance
0.00
Net Common Stock Issuance
-49.45
-121.10%
-22.37
0.00
0.00
Common Stock Payments
-49.45
-121.10%
-22.37
0.00
0.00
Common Stock Dividend Paid
-12.28
+4.58%
-12.87
Cash Dividends Paid
-12.28
+4.58%
-12.87
Repurchase Of Capital Stock
-49.45
-121.10%
-22.37
0.00
0.00
Net Other Financing Charges
-23.52
-14.01%
-20.63
-21.44%
-16.99
+14.28%
-19.82
Changes In Cash
56.86
+327.80%
-24.96
-54.32%
-16.18
+93.26%
-240.02
Effect Of Exchange Rate Changes
1.39
+317.77%
-0.64
-391.74%
0.22
+140.07%
-0.54
Beginning Cash Position
105.38
-19.54%
130.98
-10.86%
146.93
-62.08%
387.50
End Cash Position
163.63
+55.28%
105.38
-19.54%
130.98
-10.86%
146.93
Free Cash Flow
37.06
-19.18%
45.85
+19.99%
38.21
+40.22%
27.25
Interest Paid Supplemental Data
10.80
-23.92%
14.20
-1.80%
14.46
+38.43%
10.44
Income Tax Paid Supplemental Data
0.83
0.00
-100.00%
0.14
0.00
Common Stock Issuance
0.00
0.00
Issuance Of Capital Stock
0.00
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category